Skip to main content

Advertisement

SpringerLink
Log in

EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

References

  1. O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003; 348: 994–1004.

    Article  CAS  Google Scholar 

  2. Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML et al. Frequency of major molecular responses to imatinib or interferon alpha plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med. 2003; 349: 1423–1432.

    Article  CAS  Google Scholar 

  3. Etienne G, Cony-Makhoul P, Mahon FX . Imatinib mesylate and gray hair. N Engl J Med. 2002; 347: 446.

    Article  Google Scholar 

  4. Bekkenk MW, Vermeer MH, Meijer C, Jansen P, Middeldorp J, Stevens S et al. EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate. Blood 2003; 102: 4243.

    Article  CAS  Google Scholar 

  5. Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NKC et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant. 1999; 23: 251–258.

    Article  CAS  Google Scholar 

  6. Seggewiss R, Lore K, Greiner E, Magnusson MK, Price DA, Douek DC et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 2005; 105: 2473–2479.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service des maladies du sang, Hôpital du Haut-Lévèque, Pessac, France

    T Leguay, C Foucaud, K Bouabdallah, R Tabrizi, G Marit, A Pigneux & N Milpied

  2. Laboratoire d'Anatomo-pathologie, Hôpital du Haut-Lévèque, Pessac, France

    M Parrens & M A Belaud-Rotureau

  3. Service d'Oncologie, Clinique Bordeaux-Nord, Bordeaux, France

    O Fitoussi

Authors
  1. T Leguay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Foucaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Parrens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O Fitoussi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Bouabdallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M A Belaud-Rotureau
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Tabrizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Marit
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Pigneux
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. N Milpied
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Milpied.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leguay, T., Foucaud, C., Parrens, M. et al. EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia. Leukemia 21, 2208–2210 (2007). https://doi.org/10.1038/sj.leu.2404758

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404758

  • Springer Nature Limited

This article is cited by

Search

Navigation